Novel Real-Time Library Search Driven Data Acquisition Strategy for Identification and Characterization of Metabolites

Significance of the Topic

The structural identification of drug metabolites is essential for understanding pharmacokinetics, safety profiles and environmental impact. Traditional data-dependent MSn methods often waste cycle time on irrelevant or known compounds, limiting the discovery of low-abundance or novel transformation products. A real-time, library-driven acquisition strategy can focus MSn experiments on likely metabolites, improving both throughput and depth of analysis.

Objectives and Study Overview

This work introduces Met-IQ, a real-time library search (RTLS) driven data acquisition method implemented on the Orbitrap IQ-X Tribrid mass spectrometer. Using amprenavir metabolites as a model, the study compared standard data-dependent MS3 acquisition with Met-IQ guided acquisition to determine whether targeted MS3 on library-matched fragments increases the number and quality of identified metabolites in a single run.

Methodology and Used Instrumentation

Sample Preparation and LC/MS Conditions:

• Amprenavir (5 μM) incubated with human liver microsomes, NADPH and GSH.
• UHPLC separation (18 min) on Vanquish Horizon system in positive ion mode.
• Data acquisition on Thermo Scientific Orbitrap IQ-X Tribrid MS using data-dependent MS2 and MS3, with and without RTLS.

Real-Time Library Search Workflow:

• mzVault spectral library loaded into memory, filtered by polarity, activation mode and analyzer type.
• Each MS2 spectrum is scored by cosine similarity against library entries within m/z and collision energy tolerances.
• When a cosine score meets the threshold (e.g., ≥15), the instrument triggers targeted MS3 on that fragment in real time, otherwise proceeds with MS2 only.

Data Processing:

• FreeStyle software used to count MS2/MS3 scans and extract metabolite spectra.
• Compound Discoverer employed for structural annotation of unknown fragments.

Main Results and Discussion

Depth of Sampling:

• Met-IQ increased MS2 scan count by 3.4-fold compared to untargeted MS3 acquisition, from ~1 060 to ~3 638 scans per run.
• Targeted MS3 events dropped by over six-fold, focusing on fragments with structural relevance.

Metabolite Identification:

• Met-IQ enabled detection of 17 unique amprenavir transformation products in one analysis, versus 11 without RTLS—a 55 % increase.
• Higher-mass fragment selection improved MS3 quality and facilitated annotation of previously unknown substructures (e.g., m/z 263.1758 fragment).

Data Simplification:

• Reduced total MS3 spectra simplifies post-run data processing and decreases file size.

Benefits and Practical Applications

• More efficient use of instrument cycle time by avoiding MS3 on background or well-known compounds.
• Enhanced probability of discovering low-level, novel metabolites in a single run.
• Improved structural characterization through intelligent fragment selection and real-time decision making.

Future Trends and Opportunities

Real-time, library-driven acquisition opens avenues for:

• Integration with machine-learning models to predict fragmentation patterns and further refine dynamic acquisition.
• Expansion to other classes of small molecules and complex matrices (e.g., environmental samples, food safety).
• Automated feedback loops between data processing software and acquisition engine for fully autonomous MSn experiments.

Conclusion

The Met-IQ RTLS approach on the Orbitrap IQ-X significantly enhances metabolite discovery and structural elucidation by prioritizing MS3 acquisition on library-matched fragments. This strategy offers greater depth, efficiency and data quality in a single run, benefitting drug metabolism, toxicology and broader metabolomics applications.

Reference

Brandon Bills, Seema Sharma, William Barshop et al. Novel Real-Time Library Search Driven Data Acquisition Strategy for Identification and Characterization of Metabolites. Thermo Fisher Scientific, 2021.